The efficacy and safety of Diptptidyl peptidase-4 inhibitors combined with insulin in patients with autoimmune diabetes: A updated meta-analysis

Introduction: It is still controversial about the efficacy of Diptptidyl peptidase-4 (DPP4) inhibitors in the treatment of autoimmune diabetes, especially it is unclear whether different drugs have different efficacy for different subtypes of autoimmune diabetes. Aims: To evaluated the efficacy and...

Full description

Bibliographic Details
Main Authors: Na Wang, Teng Yang, Xiuli Feng, Guofeng Wang, Liujing
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Endocrine and Metabolic Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666396124000189